Peptides are defined as selective and efficacious signaling molecules which bind to specific cell surface receptors to trigger intracellular effects. Peptides are gaining popularity as clinical therapeutics. Peptides are highly tunable molecules that can be used to achieve desirable biocompatibility & biodegradability with simultaneously selective & potent therapeutic effects.

Get Free Sample Copy Of This Report @

The increase in prevalence of metabolic diseases & cardiovascular disorders is expected to propel the global peptide therapeutics market growth over the forecast period. For instance, as per the American Heart Association’s Heart Disease & Stroke Statistics 2018, approx 92.1 million adults in the United States are suffering from some form of CVD or the after-effects of stroke. Furthermore, the increase in healthcare expenditure is also expected to boost the global peptide therapeutics market growth. For instance, as per the information of Centers for Medicare & Medicaid Services, health spending the United States is anticipated to grow at an average rate of 5.5% per year for 2018-2027 and to reach around US$ 6.0 trillion, by 2027.

The market growth is associated with increasing investments in drug discovery, research and development activities in peptide therapeutics are mainly focused on the development of drugs about oncology followed by metabolic disorders, infectious diseases, and diabetes. The presence of a strong product pipeline in this segment is also one of the prominent factors anticipated to drive the peptide therapeutics market growth during this forecast period.

Get Discount On This Report @

Key Players

Various key players are listed in this report such as Teva Pharmaceutical Industries Ltd, Amgen Inc, PeptiDream Inc, Novartis AG, Pfizer Inc, CirclePharma, Inc., Encycle Therapeutics, Inc., Sanofi S.A., Eli Lilly and Company,  Novo Nordisk A/S, Takeda Pharmaceuticals Co. Ltd., etc.

Poor Chemical & physical stability and a short circulating plasma half-life of naturally occurring peptides are expected to hamper the global peptide therapeutics market growth. Also, the presence of stringent safety regulations may restraint the market growth.

Market Segmentation

The Global Peptide Therapeutics Market is segmented into type such as Generic, and Branded, by application such as Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and others. Further, market is segmented into route of administration such as Oral, Parental, and Others.

Also, the Global Peptide Therapeutics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Regional Analysis

The North America region is expected to held dominant position in the overall peptide therapeutics market, throughout the forecast period, due to some factors such as the increase in awareness levels relating to peptide therapeutics, products, growing necessity for diagnostics in cancer & other diseases. The rising R & D activities expenditure by government & key players is also expected to drive the peptide therapeutics market in this region. Also, the APAC is projected to register considerable growth throughout the forecast period due to high untapped opportunities, growing base of companies providing outsourcing services, low cost of raw material, and growing investments in research and development sector.

Browse Full Research Report @